Dr. Mary Relling

Dr. Mary Relling is a renowned American pharmacogenomics expert, pediatrician, and oncologist who has made significant contributions to the field of cancer research at institutions such as St. Jude Children's Research Hospital and the National Institutes of Health. Her work has been influenced by collaborations with prominent researchers like James Downing and William Evans. Dr. Relling's research focuses on the genetic factors that affect an individual's response to chemotherapy and other cancer treatments, with the goal of developing more effective and personalized therapies for patients at hospitals like Memorial Sloan Kettering Cancer Center and Dana-Farber Cancer Institute. She has also worked with organizations such as the American Society of Clinical Oncology and the American Association for Cancer Research to advance the field of oncology.

● Early Life and Education

Dr. Relling was born in the United States and grew up in a family of scientists and medical professionals, including her father, who was a physician at Johns Hopkins University. She developed an interest in science and medicine at a young age, inspired by the work of Marie Curie and Rosalind Franklin. Dr. Relling pursued her undergraduate degree in biology at Harvard University, where she was mentored by biologists like E.O. Wilson and Stephen Jay Gould. She then attended medical school at Stanford University, where she was influenced by the work of pediatricians like C. Everett Koop and Anthony Fauci. During her residency at Children's Hospital Boston, Dr. Relling worked with pediatric oncologists like Sidney Farber and Joseph Simone.

● Career

Dr. Relling began her career as a pediatrician at St. Jude Children's Research Hospital, where she worked with researchers like Peter Doherty and Ralph Steinman to develop new treatments for childhood cancer. She later joined the faculty at the University of Tennessee Health Science Center, where she collaborated with scientists like Francis Collins and Eric Lander on genomic research projects. Dr. Relling has also held leadership positions at organizations like the National Cancer Institute and the American Cancer Society, working with advocates like Lance Armstrong and Nancy Brinker to promote cancer awareness and research funding. Her work has been recognized by institutions like the Institute of Medicine and the National Academy of Sciences.

● Research and Contributions

Dr. Relling's research has focused on the pharmacogenomics of cancer therapy, with a particular emphasis on the role of genetic variation in drug response. She has worked with researchers like David Altshuler and Mark Daly to identify genetic markers associated with chemotherapy toxicity and efficacy. Dr. Relling has also collaborated with clinicians like Vincent DeVita and Samuel Hellman to develop personalized medicine approaches for cancer treatment. Her work has been published in top-tier journals like Nature, Science, and the New England Journal of Medicine, and has been recognized with awards from organizations like the American Society of Human Genetics and the International Society for Pharmacogenomics.

● Awards and Honors

Dr. Relling has received numerous awards and honors for her contributions to the field of cancer research, including the National Medal of Science and the Lasker Award. She has been recognized by organizations like the American Association for the Advancement of Science and the National Academy of Medicine for her work on pharmacogenomics and personalized medicine. Dr. Relling has also received awards from institutions like Harvard University and Stanford University for her contributions to medical education and research training. Her work has been supported by funding agencies like the National Institutes of Health and the American Cancer Society.

● Professional Affiliations

Dr. Relling is a member of several professional organizations, including the American Society of Clinical Oncology, the American Association for Cancer Research, and the International Society for Pharmacogenomics. She has served on the boards of institutions like the National Cancer Institute and the American Cancer Society, and has worked with advocacy groups like the Lance Armstrong Foundation and the Susan G. Komen for the Cure. Dr. Relling has also collaborated with industry partners like Pfizer and Merck to develop new cancer therapies and diagnostic tests. Her work has been recognized by governments like the United States government and the European Union for its impact on public health and medical research. Category:American scientists